Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention

Rolf P Kreutz1 Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA;2 Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USACorrespondence[email protected]

Jeffrey A Breall1 Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA

Anjan Sinha1 Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA

Elisabeth von der Lohe1 Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA

Richard J Kovacs1 Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA

David A Flockhart2 Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USA

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention

Citations (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date